NANETS Regional NET Education, Eastern Virginia Medical School, Norfolk, VA


Join The North American Neuroendocrine Tumor Society (NANETS) and Eastern Virginia Medical School at the Regional NET Education Forum:  The Changing Face of NETs at Eastern Virginia Medical School’s Lester Hall in Norfolk, Virginia, on Saturday, February 17, 2018.  Eastern Virginia Medical School designates this live activity for a maximum of 8.75 AMA PRA Category 1 Credits.

These regional education forums bring local medical professionals together with leaders in neuroendocrine medicine to learn about and discuss NET disease and patient care in the community
and across the United States. This comprehensive, one-day program will educate participants about the standard management of patients with NETs, as well as new diagnostic and therapeutic techniques. Participants will learn about the multidisciplinary management and The Changing Face of NETs.

Physicians pictured left to right: Aaron Vinik, David Metz, Karel Pacak, Jonathan Strosberg

The Course Director is NET specialist Aaron I. Vinik, MD, PhD, FCP, MACP, FACE, Murray Waitzer Endowed Chair for Diabetes, Research, Professor of Medicine/athology/Neurobiology Director of Research and Neuroendocrine Unit, Eastern Virginia Medical School, Strelitz Diabetes Center for Endocrine and Metabolic Disorders.  The guest speakers are David Metz, MD, Professor of Medicine, Hospital of the University of Pennsylvania; Guido Rindi, MD, PhD, Professor of Medicine and Surgery, Catholic University of the Sacred Heart, Rome; Karel Pacak, MD, PhD, DSc, Senior Investigator, National Institutes of Health; and Jonathan R. Strosberg, MD, Associate Professor, H. Lee Moffitt Cancer Center.

Among the topics to be covered during the conference are:

  • Pathology of NETs
  • New Classification of NETs/Pathology (Keynote Address)
  • Pheochromocytoma/Paraganglioma Syndromes
  • NETs Functional/Molecular Imaging — Where Do Things Stand in 2018?
  • Surgical Management of MEN Syndromes
  • Nutritional Management of NETs
  • New Agents in the Treatment of NETs
  • Peptide Receptor Radionuclide Therapy (PRRT)

Click here for the full conference agenda, registration, and more information.

Print Friendly, PDF & Email